NSC |
Compound |
Enrichment |
Correlation |
NSC 130279 |
7H-1,2,3-Triazolo[4,5-d]pyrimidin-7-one, 3,4-dihydro-3-.beta.-D-ribofuranosyl- (9CI) |
0.00352002370824895 |
0.28763043 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.00352002370824895 |
-0.28745259 |
NSC 133118 |
2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) |
0.00352002370824895 |
0.097375866 |
NSC 144163 |
Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- |
0.00352002370824895 |
0.025775627 |
NSC 349622 |
Cytovaricin |
0.00407837248037199 |
-0.030187886 |
NSC 643836 |
Null |
0.00407837248037205 |
0.018003127 |
NSC 671765 |
3-[2-pyrrolidino] ethoxy-17-butyl-17-aza-1,3,5(10)-estratriene-16,17.alpha.-dione |
0.00407837248037205 |
-0.085854922 |
NSC 684043 |
1H-Imidazole-4-carboxamide, 5-[[(2-amino-2-carboxyethyl)thio]azo]- |
0.00407837248037205 |
0.22066625 |
NSC 684144 |
Null |
0.00407837248037205 |
-0.04586207 |
NSC 697286 |
LY 294002 |
0.00407837248037205 |
-0.053824051 |